Staphylococcus aureus Community-acquired Pneumonia in Children After 13-Valent Pneumococcal Vaccination (2008-2018): Epidemiology, Clinical Characteristics and Outcomes.
Autor: | Aguilera-Alonso D; From the Pediatric Infectious Diseases Unit, Department of Pediatrics, Hospital General Universitario Gregorio Marañón, Unidad de Investigación Materno-Infantil Fundación Familia Alonso (UDIMIFFA), Instituto de Investigación Sanitaria Gregorio Marañón (IiSGM), Madrid, Spain.; CIBER en Enfermedades Infecciosas (CIBERINFEC), Instituto de Salud Carlos III, Madrid, Spain., Kirchschläger Nieto S; Department of Pediatrics, Centro de Salud, Madrid, Spain., Ara Montojo MF; Pediatric Department, Hospital Universitario Quironsalud, Madrid, Spain., Sanz Santaeufemia FJ; Department of Pediatrics, Hospital Universitario Niño Jesús, Madrid, Spain., Saavedra-Lozano J; From the Pediatric Infectious Diseases Unit, Department of Pediatrics, Hospital General Universitario Gregorio Marañón, Unidad de Investigación Materno-Infantil Fundación Familia Alonso (UDIMIFFA), Instituto de Investigación Sanitaria Gregorio Marañón (IiSGM), Madrid, Spain.; CIBER en Enfermedades Infecciosas (CIBERINFEC), Instituto de Salud Carlos III, Madrid, Spain., Soto B; Department of Pediatrics, Hospital de Getafe, Madrid, Spain., Caminoa MB; Department of Pediatrics, Hospital de Torrejón, Madrid, Spain., Berzosa A; Department of Pediatrics, Hospital Clinico San Carlos, Madrid, Spain., Prieto Tato L; Department of Pediatric Infectious Diseases, Hospital Universitario Doce de Octubre, Madrid, Spain., Cercenado E; Department of Microbiology, Hospital General Universitario Gregorio Marañón, CIBERES, Centro de Investigación Biomédica en Red de Enfermedades Respiratorias, Madrid, Spain., Tagarro A; Department of Pediatrics, Hospital Infanta Sofía, Madrid, Spain., Molina Arana D; Department of Microbiology, Hospital de Getafe, Madrid, Spain., Alonso Sanz M; Department of Microbiology, Hospital Universitario Niño Jesús, Madrid, Spain., Romero Gómez MP; CIBER en Enfermedades Infecciosas (CIBERINFEC), Instituto de Salud Carlos III, Madrid, Spain.; Department of Microbiology, Hospital Universitario La Paz, Madrid, Spain., Chaves Sánchez F; Department of Microbiology, Hospital Universitario 12 de Octubre, Madrid, Spain., Baquero-Artigao F; CIBER en Enfermedades Infecciosas (CIBERINFEC), Instituto de Salud Carlos III, Madrid, Spain. |
---|---|
Jazyk: | angličtina |
Zdroj: | The Pediatric infectious disease journal [Pediatr Infect Dis J] 2022 May 01; Vol. 41 (5), pp. e235-e242. |
DOI: | 10.1097/INF.0000000000003503 |
Abstrakt: | Background: The epidemiology of community-acquired pneumonia (CAP) has changed, influenced by sociosanitary conditions and vaccination status. We aimed to analyze the recent epidemiology of bacterial CAP in hospitalized children in a setting with high pneumococcal vaccination coverage and to describe the clinical characteristics of pediatric Staphylococcus aureus CAP. Methods: Children <17 years old hospitalized from 2008 to 2018 with bacterial CAP in 5 tertiary hospitals in Spain were included. Cases with pneumococcal CAP were randomly selected as comparative group following a case-control ratio of 2:1 with S. aureus CAP. Results: A total of 313 bacterial CAP were diagnosed: Streptococcus pneumoniae CAP (n = 236, 75.4%), Streptococcus pyogenes CAP (n = 43, 13.7%) and S. aureus CAP (n = 34, 10.9%). Throughout the study period, the prevalence of S. pyogenes increased (annual percentage change: +16.1% [95% CI: 1.7-32.4], P = 0.031), S. pneumoniae decreased (annual percentage change: -4.4% [95 CI: -8.8 to 0.2], P = 0.057) and S. aureus remained stable. Nine isolates of S. aureus (26.5%) were methicillin-resistant. Seventeen cases (50%) with S. aureus CAP had some pulmonary complication and 21 (61.7%) required intensive care. S. pneumoniae CAP showed a trend toward higher prevalence of pulmonary complications compared with S. aureus CAP (69.1% vs. 50.0%, P = 0.060), including higher frequency of pulmonary necrosis (32.4% vs. 5.9%, P = 0.003). Conclusions: The incidence of S. aureus CAP in children remained stable, whereas the prevalence of pneumococcal CAP decreased and S. pyogenes CAP increased. Patients with S. aureus presented a high frequency of severe outcomes, but a lower risk of pulmonary complications than patients with S. pneumoniae. Competing Interests: The authors have no funding or conflicts of interest to disclose. (Copyright © 2022 Wolters Kluwer Health, Inc. All rights reserved.) |
Databáze: | MEDLINE |
Externí odkaz: |